Retrospective study of 103 presumed cases of tick (Ixodes holocyclus) envenomation in the horse     

Ruppin M  Sullivan S  Condon F  Perkins N  Lee L  Jeffcott LB  Dart AJ 《Australian veterinary journal》2012,90(5):175-180

Objective Review 103 cases of presumed tick envenomation in horses. Design Retrospective study. Method Variables, including date of presentation, age, breed, weight, presence of ticks, gait and respiration scores, duration of recumbency, treatment, outcome and complications were recorded. A series of univariable screening tests were performed and used in a multivariable logistic regression model. Results There were a total of 103 cases affecting 10 breeds, aged between 1 week and 18 years of age. Horses >6 months old and weighing >100 kg had a higher odds of death than those <6 months old and <100 kg. Cases were seen from North Queensland to the central coast of New South Wales and were more likely to present in the warmer months. There was no association between the number of ticks found on an animal and death. Horses with a higher respiratory score had higher odds of dying, but there was no association between gait score and survival. Horses recumbent >120 h after presentation had higher odds of dying. Complications were reported in 35% of horses. The odds ratio for survival was higher for horses receiving >0.5 mL/kg of tick antiserum. Overall, 74% of horses survived. Multivariable modelling was limited by the small sample size. Conclusion In general, tick envenomation in horses follows the geographic distribution of Ixodes holocyclus. Tick antiserum administered at >0.5 mL/kg increases the odds of survival. It would appear that the complications associated with managing a recumbent horse increase the odds of death.  相似文献   

山羊痘病毒糖蛋白基因ORF112的原核表达及多克隆抗体的制备     

郑敏  李春艳  陆文俊  莫胜兰  屈素洁  粟艳琼  梁媛  施开创  李军 《动物医学进展》2012,33(4):1-5

为探索山羊痘病毒(GTPV)糖蛋白基因ORF112在疫苗和诊断中的应用,应用PCR技术扩增GTPV弱毒疫苗株AV 41ORF112基因,将其克隆到pET-32a载体,转化感受态细胞BL21,经IPTG诱导后获得与预期大小相符的约37ku的融合蛋白,为可溶性和包涵体表达。应用镍离子亲和树脂对可溶性表达的目的蛋白进行纯化,然后用纯化的融合蛋白免疫Balb/c小鼠,制备多克隆抗体。免疫荧光试验表明该多克隆抗体可以与GTPV反应,为GTPV新型疫苗和诊断试剂的研究奠定了基础。  相似文献   

鸡BLB重组蛋白的原核表达及多抗制备     

李行  高彩霞  蔡文博  杨柳  武永淑  张伟  韩凌霞 《中国预防兽医学报》2012,34(1):68-70

为分析鸡主要组织相容性复合体(MHC)Ⅱ类抗原β亚基BLB蛋白在鸡脾脏中的表达情况,本研究采用RT-PCR技术从鸡脾细胞中扩增了BLB基因的保守区第3外显子的部分序列,大小约为380 bp.将其克隆于表达载体pET-30a(+)中.在大肠杆菌BL21 (DE3)中,经IPTG诱导表达,获得大小约为19ku以包涵体形式存在的His-BLB重组蛋白.切取含有重组蛋白的SDS-PAGE胶免疫实验兔,获得抗血清.以制备的血清通过westemblot在鸡脾脏中检测到MHCⅡ类分子特异性条带,其大小约为28 ku,与BLB天然蛋白的大小相符合.本研究为进一步分析MHC-Ⅱ类分子在鸡体内的蛋白表达水平提供了依据.  相似文献   

苏丹红Ⅰ直接竞争ELISA检测试剂盒的研制   总被引：2，自引：0，他引：2  

张明洲  方结红  陈宗伦  胡华军  杨岭  刘军  俞晓平 《核农学报》2010,24(2):341-348

直接包被多克隆抗体建立了苏丹红ⅠELISA检测技术,研制苏丹红ⅠELISA检测试剂盒。结果表明,制备的多克隆抗体对苏丹红Ⅰ亲合力强、特异性高,试剂盒标准曲线呈典型的S型,符合4参数logit曲线拟合,线性范围为1.55～100μg/L,50%抑制率(IC50)为13.52μg/L,灵敏度(IC10)为1.95μg/L,平均批内与批间变异系数分别为7.6%与10.6%,与苏丹红Ⅱ、Ⅲ的交叉反应率分别为4.40%和1.70%,与苏丹红Ⅳ及其他违禁食品染色剂交叉反应率低于0.01%;干辣椒、辣椒粉、辣椒油与辣椒酱等4种样品的苏丹红平均添加回收率分别为88.1%、91.4%、78.2%和84.3%,最低检测限分别为1.82、1.71、2.19和2.12μg/kg;与HPLC检测方法具有较高的相符性,4种样品相关系数分别为0.95,0.94,0.86和0.87;该试剂盒在4℃下至少可保存180d,可用于辣椒及其制品中苏丹红Ⅰ的批量快速低成本筛查。  相似文献   

菠萝AcPLD2基因多克隆抗体制备及其在果实黑心病发生中的表达分析     

洪克前  谷会  陈丽  姚全胜 《热带作物学报》2022,43(2):244-250

菠萝是中国最具有特色和竞争优势的热带水果之一,但采后菠萝果实不耐贮藏,极易发生黑心病,严重影响果实品质和商品率,而且威胁菠萝产业的健康发展.因此减少采后菠萝损失直接关系到热区农民的经济收入.黑心病是采后菠萝果实一种常见的生理性病害,由于该病的生理机制尚不清楚,所以国内外尚未有完全控制黑心病发生的方法.目前关于菠萝黑心病...  相似文献   

牛病毒性腹泻病毒Core蛋白的原核表达及多克隆抗体制备     

张康  张璇  闫遵祥  王磊  张凯  张景艳  罗永江  仇正英  薛欢  李建喜 《浙江农业学报》2019,31(11):1819

为制备牛病毒性腹泻病毒(BVDV)的Core蛋白及其多克隆抗体,根据Core蛋白的编码基因序列,设计合成一对特异性引物,利用RT-PCR扩增BVDV Core基因并定向插入Pet30a载体中,构建重组质粒Pet30a-Core,经酶切鉴定后转化大肠埃希菌TOP 10感受态细胞,筛选获得阳性重组菌,以IPTG进行诱导后成功表达出分子质量为20 ku的重组Core蛋白。将诱导表达的蛋白产物经融合蛋白的Ni柱亲和法进行纯化,利用纯化的重组蛋白免疫新西兰白兔制备多克隆抗体,并利用间接ELISA法测出多克隆抗体效价达到1∶512 000。蛋白质印迹法(Western blot)和间接免疫荧光试验(IFA)证实,多克隆抗体可与细胞中的BVDV抗原发生反应,具有良好的免疫原性和特异性。本实验成功制备了BVDV重组Core蛋白的兔源多克隆抗体,为BVDV的检测及其Core蛋白功能研究奠定了基础。  相似文献   

鸭补体调节因子H的原核表达及多克隆抗体制备     

王向丽  李德龙  谷九龙  刘海兰  孟雅娜  陈思怀  唐发书  李继祥 《动物医学进展》2019,40(8):40-43

为制备鸭补体调节因子H(CFH)的多克隆抗体,从健康雏鸭的肝脏组织中提取总RNA及反转录合成cDNA,PCR扩增补体调节因子H基因的2个片段H1和H2,插入到载体pMD19-T,测序正确后,将目的基因分别克隆至原核表达载体pCold-TF,转化至大肠埃希菌BL21(DE3),用IPTG诱导表达蛋白,重组蛋白经SDS-PAGE检测,镍柱亲和层析纯化的重组蛋白免疫新西兰大白兔,制备多克隆抗体。结果表明,成功构建重组表达质粒pCold-TF-H1和pCold-TF-H2,SDS-PAGE检测重组蛋白为可溶性表达,TF-H1和TF-H2多克隆抗体效价均超过1∶10000。所制备的多克隆抗体可以为进一步研究鸭CFH的功能奠定基础。  相似文献   

猪腺病毒3型Protease蛋白在大肠杆菌中的表达及其抗体制备     

吴思雯  胡聪  唐青海  韩涛涛  刘祯珍  向冬梅  王姝姝  李彦  杨海  王芳宇 《中国畜牧兽医》2019,46(6):1764-1773

试验旨在研究猪腺病毒3型（PADV3） Protease蛋白在大肠杆菌中的表达,并制备该蛋白的多克隆抗体。利用PCR扩增PADV3 Protease基因,构建重组原核表达载体pET28a-PADV3-Protease和真核表达载体pEGFP-PADV3-Protease,采用双酶切和测序鉴定;将原核表达载体pET28a-PADV3-Protease转化大肠杆菌BL21（DE3）感受态细胞得到重组原核表达菌株,经IPTG诱导收集蛋白,采用SDS-PAGE和Western blotting鉴定,将目的蛋白纯化后与佐剂乳化制备免疫原免疫家兔,制备Protease蛋白多克隆抗体;将真核表达载体pEGFP-PADV3-Protease转染HEK293细胞经G418筛选建立稳定表达EGFP-Protease融合蛋白的细胞系,以该稳定表达细胞系为包被抗原,采用免疫过氧化物酶单层细胞染色法（IPMA）检测抗体的免疫活性与抗体滴度。结果显示,Protease基因开放阅读框（ORF）为615 bp,原核表达系统中Protease蛋白以包涵体形式存在,分子质量大小为23 ku,与真核细胞表达的Protease蛋白分子质量一致,该蛋白在细胞核与细胞质中均有分布,制备的Protease蛋白多克隆抗体能与EGFP-Protease融合蛋白稳定表达真核细胞系发生特异性的反应,与对照细胞无反应。本试验构建了Protease蛋白原核表达菌株和真核表达细胞株,制备的PADV3-Protease蛋白多克隆抗体免疫活性良好,为进一步研究Protease蛋白的生物学功能和PADV3的血清学诊断提供了基础材料。  相似文献   

猪NLRP6蛋白的原核表达、纯化及其多克隆抗体的制备     

杨文静  李玉鹏  梁冬梅  王倩  杨升  乔家运  姚胜宁  李海花 《中国畜牧兽医》2019,46(9):2707-2714

试验旨在表达、纯化猪NLRP6蛋白,并制备鼠抗NLRP6多克隆抗体。根据猪NLRP6全基因核苷酸序列（GenBank登录号：XM_003124236.4）设计特异性引物,利用PCR方法从pMD-19T-NLRP6重组载体中扩增NLRP6基因片段,将扩增产物与原核表达载体pET-32a（+）连接,获得重组质粒pET-32a-NLRP6,经抗性筛选阳性菌、双酶切鉴定、PCR及测序分析后,将其转化大肠杆菌Rosetta（DE3）感受态细胞中,并进行IPTG诱导表达及Western blotting鉴定。对获得的重组融合蛋白进行可溶性分析,经变性、镍柱亲和纯化、复性后得到纯化的融合蛋白,将其免疫BALB/c小鼠制备多克隆抗体。结果显示,试验成功克隆大小约为576 bp的NLRP6基因序列,经鉴定重组质粒pET-32a-NLRP6构建正确,通过IPTG诱导获得大小约34 ku的NLRP6重组融合蛋白,Western blotting分析表明其与小鼠抗6×His单克隆抗体呈阳性反应。可溶性分析结果显示,NLRP6重组融合蛋白以包涵体形式存在,约占95%。纯化的NLRP6重组融合蛋白免疫BALB/c小鼠获得多克隆抗体,经Western blotting分析显示出特异性反应。本试验成功制备了具有免疫原性的NLRP6蛋白及其鼠源多克隆抗体,为NLRP6蛋白生物学功能及相关疾病致病机制研究提供了基础材料。  相似文献   

Prokaryotic Expression and Polyclonal Antibody Preparation of African Swine Fever Virus Georgia 2007/1 Strain CD2v Protein     

REN Xiao  WU Jing  YU Hainan  LIN Weidong  HOU Shaohua  GUO Xiaoyu  ZHU Hongfei 《中国畜牧兽医》2019,46(12):3698-3706

The study was aimed to express the EP402R gene of African swine fever virus (ASFV) Georgia 2007/1 strain via prokaryotic expression system,obtain the recombinant CD2v protein,and prepare polyclonal antibodies against the purified recombinant CD2v protein.After codon optimization,ASFV EP402R full-length gene was linked into pET-28a(+) expression vector to construct prokaryotic recombinant expression plasmid.After induction by 1 mmol/L IPTG at 16 ℃ for 12 h,the recombinant protein was identified by SDS-PAGE and Western blotting.The purified recombinant CD2v protein was used as immunogen to prepare mouse anti-CD2v polyclonal antibodies.The antibody titer was measured by indirect ELISA and the specificity was further analyzed by indirect immunofluorescence assay (IFA) and Western blotting.The results showed that ASFV EP402R gene was successfully cloned into pET-28a(+),and pET-28a-EP402R was obtained.The recombinant plasmid was transformed into E.coli BL21(DE3) for expression,the recombinant protein was expressed mainly in the form of inclusion bodies,with molecular mass at about 47 ku,while some of the recombinant protein could also exist in a soluble form.Western blotting results showed that the purified protein had good immunoreactivity.The indirect ELISA result showed that the polyclonal antibodies had a high titer of 1:512 000,IFA and Western blotting results indicated that it could specifically recognize recombinant CD2v protein.These results confirmed the recombinant CD2v protein expressed via prokaryotic system had good immunogenicity,and the prepared polyclonal antibodies had high titer and specificity.This research provided technical support for further study of ASFV EP402R biological function,as well as its gene-deletion based vaccine development.  相似文献